You are being so stupid about Leslies it was a call on CNBC that I brought here as Scott's call.. I always said it was his idea email him!!!
I totally agree. You know my opinion on SNAP. I said from the very start, before you had even heard of it, at $38.... it was the next FB. You mocked me.Van it may be seven! I don't have the time to go get you every one but here's another!
each time the stk has been around $71 it has worked out-
You have talked about LESL 1000X Stoney!You are being so stupid about Leslies it was a call on CNBC that I brought here as Scott's call.. I always said it was his idea email him!!!
I like CRSR.
3> LESL-- I smell an investment! IRA this!
..
One of the things I am famous for is my relative strength. Ask me to lift something I do. complain about it later... So the market is down alot Apple is off 10% and the average small stk is off 20%- Lets Take A Look at The Green Market
stonedinvestor said:
I have cash for one more Van>>> But
GREEN MARKET PORTFOLIO....
Zymeworks $33--> $37 1/3 sld. Now $28+ Holding up great!
ATOSSA- In low $3's now $3.13 Flat
SRAD- In 26 now 22 Not Good!
WSC In $30 area now $ 31.67 What a champ!
JOAN- in at $11 area now $10.76 boreing AF
SPT (SOLD big gain)
SNAP (sold gain)
OSUR Not sure where I bought now $11- I'm a believer own it everywhere!
ARRY Bought $17 area now $16.80
LIFE bought $11.30 Now $8.67 -Not good but I have that insider buy in toggle off...
Hey thanks for the heads up on this CO!!!!Keep your eyeballs on OCGN, it's going to move. Which direction? Has huge short selling, so good news brings the squeeze. Bad news equals death. Gamble anyone? Sky high IV in the options market.
- The World Health Organization (WHO) has further delayed the emergency use authorization (EUA) for Covaxin, a COVID-19 vaccine developed in India. Ocugen Inc (NASDAQ: OCGN) is the U.S. partner for the vaccine.
- According to sources, the global body has sent more technical queries to its manufacturer Bharat Biotech.
- Without EUA, Covaxin would not be considered an accepted vaccine by most countries around the world. WHO's queries for Bharat Biotech come despite the drugmaker asserting that it has submitted all data required for clearance.
- The indication of a delay comes merely days after the Union Health Ministry hinted that the global body was likely to give its nod anytime soon.
